본문영역
-
Device/ICT
Coloplast Korea steps up patient support as catheter coverage expands
Coloplast Korea is strengthening patient education, counseling and direct support services ahead of a Dec. 1 increase in insurance coverage for self-catheterization, aiming to help...
Lee Han-soo
2026-10-06 10:42 AM
-
Hospital
Tumor suppressor RB1 loss marks aggressive liver cancer subtype: AMC study
Korean researchers have identified the loss or inactivation of both copies of the tumor suppressor gene RB1 (retinoblastoma) as a marker of an aggressive form of hepatocellular car...
Kim Yoon-mi
2026-10-06 1:30 PM
-
Hospital
Trainee doctors warn pediatric ER raid could deter emergency care
Trainee doctors and young pediatricians have criticized a recent police raid on Ajou University Hospital’s Pediatric Specialized Emergency Medical Center, warning that what they ca...
Kim Jung-hyun
2026-10-06 2:30 PM
-
Pharma
Lilly-backed OliX’s MARC1 drug faces MASH test beyond liver fat loss
As competition in metabolic dysfunction-associated steatohepatitis (MASH) drug development increasingly centers on GLP-1 therapies, OliX Pharmaceuticals is taking a different route...
Hong Sook
2026-10-06 3:55 PM
-
Device/ICT
Sky Labs begins UK validation study for CART BP Pro cuffless blood pressure monitor
Sky Labs has launched a clinical validation study in the U.K. for its CART BP Pro cuffless blood pressure monitor, seeking recognition from the British and Irish Hypertension Socie...
Lee Han-soo
2026-10-06 3:36 PM
-
Bio
Genome & Company to present GENC-116 kidney fibrosis data at ASN Kidney Week
Genome & Company said Tuesday it will present new preclinical data on GENC-116, its NUAK1-targeting fibrosis drug candidate, at ASN Kidney Week 2026 in Denver, Colorado, from Oct. ...
Lee Han-soo
2026-10-06 1:45 PM
-
Policy
Local governments face soaring infertility support costs as Korea expands birthrate...
Local governments are facing sharply rising financial and administrative burdens as the central government expands infertility treatment support as part of efforts to tackle Korea’...
You Ji-young
2026-10-06 1:54 PM
-
Pharma
GC Biopharma launches locally developed azelaic acid acne cream
GC Biopharma has launched Azelaheal Cream, an over-the-counter acne treatment containing azelaic acid that the company said is the first such product developed and manufactured by ...
Lee Han-soo
2026-10-06 2:23 PM
-
Pharma
HK inno.N's ecnoglutide cuts teen body weight by up to 12% in phase 1b trial
HK inno.N said Tuesday its obesity drug cut body weight by up to 12 percent in teenagers in an early-stage trial. The drug, ecnoglutide, was developed by China's Sciwind Bioscience...
Kim Ji-hye
2026-10-06 11:42 AM
-
Pharma
Celltrion prices Omlyclo 15% below Xolair in US launch
Celltrion said Turesday it has launched its omalizumab biosimilar Omlyclo in the U.S. at a wholesale acquisition cost about 15 percent below that of the reference drug Xolair, as t...
Kim Yoon-mi
2026-10-06 10:30 AM
-
Device/ICT
Coreline Soft wins JRS certification for lung nodule AI
Coreline Soft said its AI-powered lung nodule detection software has received certification from the Japan Radiological Society (JRS), following regulatory approval in Japan last m...
Lee Han-soo
2026-10-06 10:34 AM
-
Pharma
Samjin Pharm selected for government's World Class Plus program
Samjin Pharmaceutical will receive up to four years of government research and development (R&D) funding under the 2026 World Class Plus Project, the company said.The company recei...
Kim Ji-hye
2026-10-06 12:57 PM
-
Pharma
Jeil Pharmaceutical gets government 'K-VIP' support for overseas partnering
Jeil Pharmaceutical said Tuesday that it has been selected for a government program supporting Korean pharmaceutical and biotech companies’ overseas expansion.The company was selec...
Kim Yoon-mi
2026-10-06 11:25 AM
-
Device/ICT
CGBio to train doctors from 15 countries in regenerative aesthetics in Bali
CGBio will host Meet the Masters in Bali 2026 on Oct. 16-17, bringing together about 110 medical professionals from 15 countries for training in regenerative aesthetic procedures.T...
Kim Yoon-mi
2026-10-06 10:49 AM
-
Pharma
Yuhan to showcase CDMO capabilities at CPHI Milan 2026
Yuhan Corp. will operate an independent booth at CPHI Milan 2026 in Milan, Italy, from Tuesday to Thursday to showcase its contract development and manufacturing organization (CDMO...
Lee Han-soo
2026-10-06 11:00 AM
-
Hospital
SNUBH study flags hidden risk in heart failure recovery
Heart failure patients whose main pumping chamber improves after treatment may still face a substantially higher risk of death when the left atrium fails to recover alongside it, a...
Lee Han-soo
2026-10-05 8:30 AM
-
Special
[Interview] Yuyu Pharma CEO Robert Yu finds his second act on YouTube
Robert Yu once wanted to be an actor. He became a pharmaceutical executive, but the camera never lost its appeal. Now, the Yuyu Pharma CEO is hosting a YouTube podcast where feline...
Lee Han-soo
2026-10-02 4:47 PM
-
Pharma
'Keytruda-enfortumab combo cuts death risk by 50% in bladder cancer patients unfit for...
Perioperative Keytruda (pembrolizumab) plus enfortumab vedotin improved survival in cisplatin-ineligible muscle-invasive bladder cancer (MIBC) patients, who previously went straigh...
Kim Ji-hye
2026-10-02 5:45 PM
-
Pharma
AZ's Breztri offers alternative for COPD patients who struggle with dry-powder...
Chronic obstructive pulmonary disease (COPD) patients who struggle to inhale strongly enough to use dry-powder inhalers (DPIs) may have another treatment option following the reimb...
Kim Ji-hye
2026-10-02 2:26 PM
-
Bio
IQVIA Korea revenue nearly triples in decade as clinical research, data biz expands
IQVIA Korea posted revenue of 196.11 billion won ($144.77 million) in 2025, up 190 percent from 67.62 billion won in 2015, the company said Friday.The Korean unit of IQVIA, formed ...
Kim Ji-hye
2026-10-02 2:52 PM
-
Hospital
[Interview] Ewha Mokdong builds its next decade around women's cancer, urology...
Marking its 33rd anniversary on Oct. 6, Ewha Womans University Mokdong Hospital is concentrating staff and investment in women’s cancers, urology and blood cancers as it prepares f...
Lee Han-soo
2026-10-01 4:17 PM
-
Bio
Samsung Bioepis, Teva expand biosimilar partnership with Fasenra, Ilaris candidates
Samsung Bioepis said Friday that it has partnered with Teva Pharmaceutical Industries to develop and commercialize two biosimilar candidates referencing Fasenra and Ilaris in the U...
Lee Han-soo
2026-10-02 1:13 PM
-
Hospital
[Interview] ‘Treatment remains an option even for nonagenarian lung cancer patients’
As lung cancer treatment options expand, doctors should assess elderly patients based on their overall condition, functional status, comorbidities and willingness to undergo treatm...
Hong Sook
2026-10-02 3:24 PM
-
Policy
Mounjaro safety checks surge in Korea, with over 3,000 involving minors
Drug utilization review (DUR) checks for obesity drug Mounjaro reached 2.64 million in the year following its Korean launch, including more than 3,000 checks involving minors, gove...
Lim Su-min
2026-10-02 1:59 PM
-
Device/ICT
Humedix to invest ₩3.3 bil. in medical product R&D under government program
Humedix will invest about 3.3 billion won ($2.4 million) in research and development through 2029 after being selected for a government program supporting companies with global gro...
Kim Yoon-mi
2026-10-02 2:38 PM
-
Pharma
Huons to unveil preclinical data on GI, oral obesity drug candidates at global meetings
Huons will unveil preclinical data on investigational gastrointestinal and oral obesity drug candidates at two global conferences later this year after the studies were selected as...
Kim Yoon-mi
2026-10-02 11:40 AM
-
Policy
Health insurance arrears over ₩10 mil. more than double in 4 years
Large health insurance arrears among self-employed subscribers more than doubled over four years, even as total overdue premiums remained virtually unchanged, government data showe...
Lim Su-min
2026-10-02 2:04 PM
-
K-Beauty
KHIDI opens Paris K-beauty hub to help Korean SMEs break into Europe
The Korea Health Industry Development Institute (KHIDI) has opened a K-beauty flagship hub in Paris, aiming to help small- and medium-sized Korean cosmetics companies gain a footho...
Lee Han-soo
2026-10-02 11:17 AM
-
Hospital
Severance becomes 1st Korean hospital to perform 10,000 atrial fibrillation procedures
Severance Cardiovascular Hospital has performed 10,000 atrial fibrillation ablation procedures, becoming the first single medical institution in Korea to reach the milestone, the h...
Lee Han-soo
2026-10-02 1:28 PM
-
Hospital
Kyung Hee Medicine plans new complex to triple research space under 5-year strategy
Kyung Hee University Medical Center unveiled a five-year plan Friday to expand research facilities and strengthen care across its hospitals, while adopting the new English name “Ky...
Lee Han-soo
2026-10-02 12:57 PM
-
Hospital
Staff shortages behind 77% of ER care restrictions in Korea
Workforce shortages accounted for 77 percent of department-specific emergency room care restriction notices in Korea in the first half of this year, with pediatrics reporting the m...
Lim Su-min
2026-10-02 1:40 PM
-
Opinion
[Global Pharma Leadership Voices] Why are patients still waiting for innovation? The...
Global Pharma Leadership Voices is a thought-leadership series featuring columns written by general managers of multinational pharmaceutical companies operating in Korea. Through t...
Claire Kim
2026-10-01 10:56 AM
-
Policy
Korea spends ₩394.1 bil. on diabetes complications, but hasn't assessed newer...
Korea's national health insurance system spent 394.1 billion won ($289 million) on care for type 2 diabetes patients with serious complications in 2025, but the government has not ...
Lim Su-min
2026-10-02 2:07 PM
-
Policy
KAIST finds ‘hidden amplification switch’ controlling lymphatic vessel signaling
Korean researchers have identified a previously unknown mechanism that amplifies lymphatic vessel signaling, offering a potential new target for research into lymphedema and cancer...
Lee Han-soo
2026-10-02 1:16 PM
-
Special
[Interview] Vetter outlines LC-MS role in oligonucleotide development and quality control
Developers of oligonucleotide therapies should consider future quality control requirements when establishing analytical methods in early development, according to Melanie Zerulla-...
Lee Han-soo
2026-09-29 11:20 AM
-
Pharma
Imdelltra extends survival in relapsed small cell lung cancer, Korean investigator says
Imdelltra (tarlatamab) extended survival over chemotherapy in second-line relapsed or refractory extensive-stage small cell lung cancer (ES-SCLC), a Korean lead investigator said a...
Kim Ji-hye
2026-10-01 6:12 PM
-
Hospital
SNUBH’s Oh Joo-han elected to International Board of Shoulder and Elbow Surgery
Professor Oh Joo-han of the Department of Orthopedic Surgery at Seoul National University Bundang Hospital (SNUBH) has been elected to the International Board of Shoulder and Elbow...
Kim Yoon-mi
2026-10-02 9:00 AM
-
Hospital
[Interview] Pluvicto moves earlier in prostate cancer treatment, but Korean patients face...
Radioligand therapy (RLT) is gaining ground in metastatic castration-resistant prostate cancer (mCRPC), but experts say broader regulatory approval and reimbursement are needed to ...
Hong Sook
2026-10-02 9:00 AM
-
Bio
After scrapping merger, AriBio Group bets on AR1001 and non-pharma cash to fund...
AriBio Group plans to channel earnings from lighting and electrical construction into dementia drugs, vaccines and brain health care, outlining a broader growth strategy as it prep...
Lee Han-soo
2026-10-01 1:58 PM
-
Policy
Korea picks Namwon for national medical school, targeting 2029 opening
Korea will establish a national graduate medical school in Namwon, North Jeolla Province, with the institution scheduled to open in 2029 and admit 100 students annually beginning i...
Kwak Sung-sun
2026-10-01 4:38 PM
-
Pharma
Huons signs Korea distribution deal for Japanese encephalitis vaccine Imojev
Huons has signed an exclusive agreement to distribute Japanese encephalitis vaccine Imojev in Korea as the company expands its vaccine business.The Korean pharmaceutical company sa...
Kim Yoon-mi
2026-10-01 4:51 PM
-
Device/ICT
Sky Labs signs ₩4.9 bil. deal to supply Cart O2 oximeters to Daewoong
Sky Labs will supply 4.9 billion won ($3.6 million) worth of its Cart O2 ring-type pulse oximeter to Daewoong Pharmaceutical in the second half of 2026, the company said Thursday.S...
Kim Ji-hye
2026-10-01 4:18 PM
-
Device/ICT
MEDICAL IP targets low-resource countries with AI-powered TB screening tool
MEDICAL IP, a Korean developer of medical imaging AI and digital twin software, is seeking to deploy its chest X-ray (CXR) analysis software into tuberculosis (TB) screening progra...
Kim Ji-hye
2026-10-01 3:23 PM
-
Bio
Samsung Biologics takes ADC, next-generation CDMO push to 4 global industry...
Samsung Biologics said Thursday it will promote its expanding antibody-drug conjugate (ADC) and next-generation biologics capabilities at four pharmaceutical and biotechnology even...
Lee Han-soo
2026-10-01 1:28 PM
-
Pharma
Korea expands Tevimbra coverage to five indications in ESCC, gastric cancer and NSCLC
BeOne Medicines Korea said Thursday that Korea’s national health insurance now covers its programmed cell death protein 1 (PD-1) inhibitor Tevimbra (tislelizumab) in five indicatio...
Kim Ji-hye
2026-10-01 2:31 PM
-
Pharma
Celltrion expands European reach with tender wins for 3 new products
Celltrion is gaining ground in smaller European pharmaceutical markets, with three of its newer products securing national and hospital tenders across Norway, Denmark, Finland and ...
Lee Han-soo
2026-10-01 10:10 AM
-
Pharma
Wegovy pill users lose 4.1% weight in 3 months after switch from GLP-1 injectables
Adults with obesity or overweight who switched from injectable semaglutide or tirzepatide to once-daily oral semaglutide (Wegovy pill) and persisted on therapy for three months had...
Kim Ji-hye
2026-10-01 9:59 AM
-
Hospital
Police raid of pediatric ER during treatment sparks controversy
Police executed a search-and-seizure warrant at a university hospital’s pediatric emergency center on Wednesday, prompting criticism that the investigation disrupted care for criti...
Song Soo-youn
2026-10-01 4:27 PM
-
Policy
Korea urged to rethink generic drug preferences to expand access to innovative...
Korea should scrap pricing preferences for certain domestic generic drugmakers and promote price competition, potentially freeing up health insurance funds to improve access to inn...
Lim Su-min
2026-10-01 3:15 PM
-
Bio
CGBio promotes FACETEM, expands Latin America push at Colombia symposium
CGBio held a medical aesthetics symposium in Colombia to promote its calcium hydroxyapatite filler FACETEM and strengthen its presence in the Latin American market.The Korean medic...
Kim Yoon-mi
2026-10-01 1:39 PM